Revance Therapeutics Inc (RVNC)

[soma2022]

what am I missing guys? Please walk me through the graphs they presented at ASDS and your interpretation because they are not a 1 point improvement from what I read as 70% of the trial participants had a severe GLS score which is 3 and to drop to none or mild is a 2 to 3 point drop on the scale, not a 1 point drop as Evolus had done in their past 20U trial. I am open to hearing out clear explanations. Be quantitative with your explanation of the graph and make specific reference to where on x and why axis labels I should be paying attention and how many weeks and percentage of responders so I can follow your logic.